Search

Learn how tiny sensors made of nanotubes could serve as implantable devices that offer a noninvasive way to monitor cancer and its treatments.

… Tuesday, March 14, 2017 Summary It is difficult to monitor diseases like cancer without repeated biopsies and imaging scans. A solution could be offered by the field of nanotechnology , in the form of tiny sensors made up of carbon nanotubes. The sensors could be implanted under the skin, and a small

Dr. Bob Li will present registrational phase II data from the first-ever trial of a drug that blocks cancer gene KRAS.

… Friday, January 29, 2021 International scientists, researchers, physicians and patient advocates in the field of lung cancer and thoracic malignancies will tune in January 28-31, 2021, for the 2020 World Conference on Lung Cancer (WCLC) hosted by the International Association for the Study of Lung Cancer

Learning more about epithelioid hemangioendothelioma (EHE) is an ongoing mission of MSK’s sarcoma research.

… Wednesday, July 21, 2021 Memorial Sloan Kettering has been a leader in the care of sarcoma patients for decades, treating about 70% of the cases in the New York City tri-state area. A disease largely affecting young people, sarcoma is a rare cancer of the bones and soft tissues with more than 50 subtypes

Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (COTELLIC®) for the treatment of adult patients with the family of blood diseases know as histiocytic neoplasms (HN). These diseases include: Erdheim-Chester Disease, Rosai-Dorfman, and Langerhans Histiocytosis. Cobimetinib is an oral inhibitor of MEK1 and MEK2 currently approved to treat melanoma.

… Tuesday, November 1, 2022 Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (Cotellic ® ) for the treatment of adult patients with the family of blood diseases known as histiocytic neoplasms

Learn how high-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or radiation.

… Monday, June 30, 2025 For people with  prostate cancer  considered “intermediate risk” —  small tumors confined to one area of the prostate – doctors are increasingly using a treatment known as  focal therapy  (partial gland ablation). One approach uses an advanced and highly precise energy source known

Learn how Memorial Sloan Kettering Cancer Center nurse Margaret Bediones improves the health of underserved communities at the MSK Ralph Lauren Center in Harlem through community outreach focused on cancer prevention and screening.

… Wednesday, January 17, 2024 For nurse Margaret Bediones, RN, taking care of people extends far beyond the walls of the MSK Ralph Lauren Center (RLC) — part of Memorial Sloan Kettering Cancer Center (MSK) — in Harlem. Margaret is committed to improving the health of people from underserved areas across

Meet David, a patient representative at MSK, who makes his voice heard is as a member of MSK’s LGBTQ Clinical Advisory Committee. Founded in 2017, the committee advises MSK staff on the clinical care of LGBTQ patients and provides strategic direction for the advancement of care for LGBTQ populations.

… Tuesday, June 29, 2021 For David Jay Smith, coming out was like Dorothy entering Oz. “My world went from black and white to Technicolor,” says David, who works at Memorial Sloan Kettering as a patient representative. “It was a transformative experience.” David knew at a young age he was “different” but

Patients like Michelle benefit from the specialized skills of experts in MSK’s Rare Breast Cancer Program.

… Thursday, October 5, 2023 It all happened so fast, says Michelle Villagomez. During a mammogram in February 2022 to check out a grape-sized lump in her right breast, the medical staff told Michelle to stay for an ultrasound. Then the radiologist pulled her aside and urged her to see an oncologist. “I

Research fellow Shaniqua Hayes joined the Jason Lewis Lab at the Sloan Kettering Institute (SKI) and Memorial Hospital about a year ago, after attending an online postdoc recruiting event and picking up “good vibes” about SKI.

… Friday, September 30, 2022 Research fellow Shaniqua Hayes Shaniqua Hayes joined the Jason Lewis Lab Jason Lewis Lab at the  Sloan Kettering Institute (SKI) Sloan Kettering Institute (SKI)  and Memorial Hospital about a year ago, after attending an online postdoc recruiting event and picking up “good

In a pivotal move to revolutionize the clinical research landscape, the MSK Clinical Research Innovation Consortium (CRIC) held its inaugural kick-off meeting in November 2025. Spearheaded by founding member MSK, the meeting welcomed new CRIC members Moffitt Cancer Center, Huntsman Cancer Institute, and the Tisch Cancer Center of Mount Sinai Health System.

… Friday, March 6, 2026 In a pivotal move to revolutionize the clinical research landscape, the MSK Clinical Research Innovation Consortium ( CRIC ) held its inaugural kick-off meeting in November 2025. Spearheaded by founding member MSK, the meeting welcomed new CRIC members Moffitt Cancer Center, Huntsman